Positive expression rates of TβRII in the poorly-differentiated and lymph node metastasis groups were significantly lower compared with the well-differentiated and no lymph node metastasis groups, respectively, and the differences were found to be statistically significant (P<0.05). This evidence concerns the gene TGFBR2 and metastatic malignant neoplasm in the lymph nodes.